VIM and non-small cell lung carcinoma: Given the role of vimentin in EMT and cell migration and invasion [9], we assessed the implication of vimentin in the molecular mechanism by which IGFBP-3 inhibits the metastatic ability of HNSCC and NSCLC cells.